1. Home
  2. PODC vs XCUR Comparison

PODC vs XCUR Comparison

Compare PODC & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODC
  • XCUR
  • Stock Information
  • Founded
  • PODC 2013
  • XCUR 2011
  • Country
  • PODC United States
  • XCUR United States
  • Employees
  • PODC N/A
  • XCUR N/A
  • Industry
  • PODC
  • XCUR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PODC
  • XCUR Health Care
  • Exchange
  • PODC Nasdaq
  • XCUR Nasdaq
  • Market Cap
  • PODC 39.6M
  • XCUR 32.4M
  • IPO Year
  • PODC N/A
  • XCUR N/A
  • Fundamental
  • Price
  • PODC $1.70
  • XCUR $4.19
  • Analyst Decision
  • PODC
  • XCUR
  • Analyst Count
  • PODC 0
  • XCUR 0
  • Target Price
  • PODC N/A
  • XCUR N/A
  • AVG Volume (30 Days)
  • PODC 70.8K
  • XCUR 21.3K
  • Earning Date
  • PODC 11-06-2025
  • XCUR 08-08-2025
  • Dividend Yield
  • PODC N/A
  • XCUR N/A
  • EPS Growth
  • PODC N/A
  • XCUR N/A
  • EPS
  • PODC N/A
  • XCUR N/A
  • Revenue
  • PODC $53,954,000.00
  • XCUR N/A
  • Revenue This Year
  • PODC $17.91
  • XCUR N/A
  • Revenue Next Year
  • PODC $14.41
  • XCUR N/A
  • P/E Ratio
  • PODC N/A
  • XCUR N/A
  • Revenue Growth
  • PODC 17.74
  • XCUR N/A
  • 52 Week Low
  • PODC $1.10
  • XCUR $1.44
  • 52 Week High
  • PODC $2.94
  • XCUR $36.00
  • Technical
  • Relative Strength Index (RSI)
  • PODC 51.61
  • XCUR 20.00
  • Support Level
  • PODC $1.50
  • XCUR $5.51
  • Resistance Level
  • PODC $1.60
  • XCUR $7.06
  • Average True Range (ATR)
  • PODC 0.13
  • XCUR 0.35
  • MACD
  • PODC 0.03
  • XCUR -0.15
  • Stochastic Oscillator
  • PODC 73.96
  • XCUR 1.23

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: